Medical Health & Life Science Research News

Detailed examination of the STD testing market - to experience a thrust with increasing healthcare expenditure

Medical Market Research

STD Testing Market (Sexually Transmitted Diseases Testing Market) is expected to garner $167.4 billion by 2020, registering a CAGR of 8.5% during the forecast period 2014-2020.

The global STD testing market based on the disease type is segmented into chlamydia testing, syphilis testing, gonorrhoea testing, herpes simplex virus testing, human papilloma virus testing, human immunodeficiency virus testing, and chancroid testing. Based on location of testing the global STD testing market is segmented into laboratory testing, and point of care (PoC) testing.

This report includes variety of diagnostic testing techniques that are used in identifying the infectious diseases. Some of the popular tests such as blood or serum testing and PCR testing are considered during estimations.

This report considers the revenue from the private as well as publicly funded STD programs. This report excludes the revenue generated from the devices sold in the market.

STD devices have been estimated according to the type of devices used during testing.

Get PDF Sample For Details:

The associated social stigma has led many STD infected individuals to refrain from testing in specialized STD clinics and Genito-Urinary Medicine (GUM) clinics that is anticipated to hamper the STD testing market growth. On the contrast, historically, it has been observed that visits to generalize public and private labs for STD testing has increased as against specialized STD clinics.

Thus, it is likely to be economic and beneficial for companies providing new STD diagnostic tests/technologies and laboratory equipment and supplies to public and private labs. The change in the consumer (STD infected and individuals opting for voluntary/CICT testing) buying behavior is thus beneficial for public or private labs and they can aim to increase the supply of STD diagnostic testing services, i.e.

expanding business horizons. This is set to supplement the growth of STD testing market in near future.

The increasing prevalence and incidence of STDs will increase the demand for diagnostic testing of STDs. However, a there are factors that are likely to restrain the STD testing market growth.

It is estimated that the impact of the drivers is likely to be higher than the restraints; the global STD testing market is likely to grow at CAGR of 8.5% during the forecast period. Additionally, a cumulative effect of the drivers and the restraints is likely to reveal few niche market opportunities that can be capitalized by companies supplying STD diagnostic tests, supplies and equipment providers and public and private labs proving beneficial for the expansion of STD testing market at a global level.

Enquiry About Report:                            


By Sexually Transmitted Disease Types

  • Chlamydia testing
  • Syphilis testing
  • Gonorrhoea testing
  • Herpes Simplex Virus testing
  • Human Papilloma Virus testing
  • Human Immunodeficiency Virus testing
  • Chancroid testing

By Location Of Testing

  • Laboratory Testing
  • Commercial/Private labs
  • Public Health Labs
  • Point of Care (PoC) testing

Access these Report

News From

Allied Market Research - Powering Enterprises through Business IntelligenceAllied Market Research
Category: Market Research Publishers and RetailersCompany about: Allied Market Research is a global market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions”. AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market dom ...
This email address is being protected from spambots. You need JavaScript enabled to view it.